Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice
- PMID: 2950265
Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice
Abstract
The in vivo significance of suppressor macrophages for antitumor immunity was investigated in a syngeneic tumor system. The presence of suppressor macrophages in the spleens of X5563 C3H/HeN tumor-bearing mice (TBM) was directly shown in vitro. Thus the addition of splenic macrophages of TBM suppressed the in vitro secondary induction of both tumor-specific cytotoxic T-cells and effector cells of the delayed-type hypersensitivity reaction. Splenic macrophages of TBM exerted suppression on tumor-specific T-cell-mediated cytotoxicity in the effector phase as well. Prostaglandin production was found to be one of the major mechanisms involved in macrophage-induced suppression. In vivo treatment of TBM with carrageenan and/or indomethacin retarded tumor growth and in parallel augmented cell-mediated cytotoxicity against X5563 cells, probably by affecting suppressor macrophages in vivo. The suppressive effect of splenic macrophages from TBM was clearly demonstrated in a tumor-neutralization test indicating that suppressor macrophages were able to exert their function in vivo as well as in vitro. All these results suggested that suppressor macrophages had in vivo significance for the suppression of the immunosurveillance of the hosts.
Similar articles
-
Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.J Immunol. 1985 Sep;135(3):2199-205. J Immunol. 1985. PMID: 3894520
-
Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.J Immunol. 1994 Aug 15;153(4):1674-86. J Immunol. 1994. PMID: 8046239
-
The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2-T cells. I. Antitumor effect of Lyt-1+2-T cells depends on the existence of adherent cells.J Immunol. 1985 Sep;135(3):2187-91. J Immunol. 1985. PMID: 3874911
-
Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.Behring Inst Mitt. 1984 May;(74):157-73. Behring Inst Mitt. 1984. PMID: 6383322 Review.
-
[Immunosuppressive phenomena in experimental tumor systems (author's transl)].Pathol Biol (Paris). 1977 Dec;25(10):735-40. Pathol Biol (Paris). 1977. PMID: 349487 Review. French.
Cited by
-
Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients.Cancer Immunol Immunother. 1988;27(2):147-53. doi: 10.1007/BF00200020. Cancer Immunol Immunother. 1988. PMID: 2970891 Free PMC article.
-
Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.Cancer Immunol Immunother. 1990;31(6):335-41. doi: 10.1007/BF01741404. Cancer Immunol Immunother. 1990. PMID: 1974826 Free PMC article.
-
Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro.Immunology. 1997 Dec;92(4):478-86. doi: 10.1046/j.1365-2567.1997.00371.x. Immunology. 1997. PMID: 9497489 Free PMC article.
-
Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.Cancer Immunol Immunother. 1990;31(6):325-34. doi: 10.1007/BF01741403. Cancer Immunol Immunother. 1990. PMID: 2386978 Free PMC article.
-
Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations.Cancer Immunol Immunother. 1994 Mar;38(3):160-6. doi: 10.1007/BF01525636. Cancer Immunol Immunother. 1994. PMID: 7907273 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources